Internal Medicine, Hematology & Oncology · Port St. Lucie, FL
NPI
1740214840
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1871 S. E. Tiffany Ave, Suite 100
Port St. Lucie, FL, 34952
Phone (772) 355-5666
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
229,887 services
Medicare patients, 2024
1,075
Average age 76
Drug cost, 2024
$7.0M
4,827 prescriptions
Company payments, 2025
$8,096
From 43 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heather Yeckes-Rodin was code Q5125 (injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram), 30,960 times for 26 patients. In total Heather Yeckes-Rodin billed 229,887 services in 173 codes, and Medicare paid $4.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-10-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 30,960 | 26 | $0.40 | $12K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 23,460 | 26 | $0.28 | $6,579 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,200 | 22 | $44.65 | $857K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 15,900 | 16 | $0.22 | $3,452 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 11,125 | 64 | $0.10 | $1,109 |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,180 | 12 | $0.08 | $497 |
| J9171 Injection, docetaxel, 1 mg | Office | 4,536 | 11 | $0.70 | $3,168 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,351 | 58 | $0.09 | $391 |
| J0897 Injection, denosumab, 1 mg | Office | 3,960 | 27 | $20.53 | $81K |
| 85025 Blood Count | Office | 2,600 | 784 | $7.57 | $20K |
| 80053 Clinical Chemistry | Office | 2,144 | 706 | $10.32 | $22K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,810 | 17 | $5.76 | $10K |
| 99213 Office E&M - Established | Office | 1,771 | 516 | $69.66 | $123K |
| 36415 Venipuncture Blood Collection | Office | 1,653 | 710 | $8.65 | $14K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,526 | 37 | $0.23 | $349 |
By year: 2022 $5.1M for 319,119 services; 2023 $4.2M for 230,056 services; 2024 $4.0M for 229,887 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,600 | 784 | $7.57 | $20K |
| 80053 Clinical Chemistry | 2,144 | 706 | $10.32 | $22K |
| 36415 Venipuncture Blood Collection | 1,653 | 710 | $8.65 | $14K |
| 82378 Clinical Chemistry | 723 | 372 | $18.50 | $13K |
| 86300 Immunoassay | 633 | 330 | $20.33 | $13K |
| 82728 Clinical Chemistry | 229 | 153 | $13.36 | $3,059 |
| 83540 Clinical Chemistry | 228 | 152 | $6.34 | $1,446 |
| 83550 Clinical Chemistry | 227 | 152 | $8.57 | $1,945 |
| 83615 Clinical Chemistry | 213 | 122 | $5.92 | $1,261 |
| 82607 Clinical Chemistry | 209 | 143 | $14.78 | $3,089 |
Medicare prescription drug claims, 2024
In 2024, the drug Heather Yeckes-Rodin prescribed most often to Medicare patients was Anastrozole, with 1,057 prescriptions and refills. In total Heather Yeckes-Rodin wrote 4,827 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 1,057 | 2,480 | 264 | $19K |
| Letrozole Generic | 374 | 683 | 83 | $6,947 |
| Tamoxifen Citrate Generic | 345 | 708 | 91 | $8,071 |
| Oxycodone Hcl Generic | 170 | 170 | 67 | $2,018 |
| Aprepitant Generic | 144 | 146 | 52 | $56K |
| Ibrance Palbociclib | 137 | 137 | 16 | $2.2M |
| Dexamethasone Generic | 132 | 140 | 50 | $1,039 |
| Exemestane Generic | 130 | 257 | 36 | $11K |
| Lorazepam Generic | 123 | 126 | 63 | $597 |
| Ondansetron Hcl Generic | 121 | 121 | 80 | $913 |
| Levothyroxine Sodium Generic | 119 | 226 | 24 | $821 |
| Prochlorperazine Maleate Generic | 106 | 106 | 70 | $1,354 |
| Prednisone Generic | 75 | 86 | 29 | $336 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 63 | 63 | 52 | $999 |
| Xarelto Rivaroxaban | 60 | 110 | 11 | $60K |
Brand drugs: - claims; generic drugs: 4,004 claims; opioid claims: 257.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heather Yeckes-Rodin $8,096 ($8,096 in general payments such as food, travel and fees) from 43 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $2,513.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $2,513 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $2,301 |
| Pfizer Inc. PFE | 28 | $373 |
| Daiichi Sankyo Inc. 4568.T | 13 | $234 |
| BeOne Medicines USA, Inc. ONC | 9 | $190 |
| Merck Sharp & Dohme LLC MRK | 7 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $165 |
| Genzyme Corporation SNY | 6 | $162 |
| Stemline Therapeutics Inc. | 9 | $154 |
| Astellas Pharma US Inc 4503.T | 6 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.